Your browser doesn't support javascript.
loading
The Use and Efficacy of Oral Phenylephrine Versus Placebo Treating Nasal Congestion Over the Years on Adults: A Systematic Review.
Livier Castillo, Jaqueline; Flores Valdés, Jose R; Maney Orellana, Maria; Satish, Sruthi; Ijioma, Chimaobi E; Benjamin, Janet; Ramirez Alvarez, Elisa; Martinez Ramirez, Marily; Arruarana, Victor Sebastian; Calderon Martinez, Ernesto.
Affiliation
  • Livier Castillo J; Internal Medicine, Universidad Autonoma de Guadalajara, Guadalajara, MEX.
  • Flores Valdés JR; Internal Medicine, Universidad Autonoma de Guadalajara, Guadalajara, MEX.
  • Maney Orellana M; Internal Medicine, Universidad de Carabobo, Valencia, VEN.
  • Satish S; Internal Medicine, Kasturba Medical College, Manipal, Manipal, IND.
  • Ijioma CE; Medicine and Surgery, Abia State University Faculty of Medicine, Uturu, Umuahia, NGA.
  • Benjamin J; Internal Medicine, Ross University School of Medicine, Miramar, USA.
  • Ramirez Alvarez E; Internal Medicine, Universidad Nacional Autonoma de Mexico, Mexico City, MEX.
  • Martinez Ramirez M; Internal Medicine, Universidad Nacional Autonoma de Mexico, Mexico City, MEX.
  • Arruarana VS; Internal Medicine, Brookdale University Hospital and Medical Center, New York, USA.
  • Calderon Martinez E; Biomedical Informatics, Universidad Nacional Autónoma de México, Mexico City, MEX.
Cureus ; 15(11): e49074, 2023 Nov.
Article in En | MEDLINE | ID: mdl-38125218
ABSTRACT
Nasal congestion is a common issue stemming from various factors such as allergies and anatomical variations. Allergic rhinitis frequently leads to nasal congestion. The pathophysiology involves inflammation, swelling, and mucus production in the nasal mucosa. Multiple treatments are available, including oral phenylephrine, an over-the-counter or prescription option. However, the effectiveness and safety of phenylephrine have been subjects of debate. This systematic review aims to provide an updated perspective on the efficacy of oral phenylephrine versus placebo in addressing nasal congestion in adults. We conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a systematic review involving searches on PubMed, Cochrane, and Scopus databases. Inclusion/exclusion criteria were defined to identify high-quality studies. The focus was on randomized controlled trials (RCTs) and case-control studies published in English between 1998 and 2023, involving adult populations. The interventions compared oral phenylephrine with placebo or standard care, with outcomes centering on changes in nasal congestion symptoms and nasal airway resistance. We identified four articles that met the criteria. These studies exhibited varied designs and populations. The findings consistently indicated that phenylephrine was not more effective than a placebo in relieving nasal congestion. This systematic review demonstrates that oral phenylephrine did not offer substantial relief from nasal congestion compared to a placebo in adults. The studies featured diverse designs, yet the prevailing conclusion was that phenylephrine's efficacy was limited. Safety assessments showed no life-threatening adverse events, with common side effects including headaches and mild discomfort. In summary, this systematic review indicates that oral phenylephrine is not significantly more effective than a placebo in alleviating nasal congestion in adults. Clinicians should explore alternative treatment options, considering the review's limitations. Additional research may be needed to clarify the role of oral phenylephrine in managing nasal congestion.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Cureus Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Cureus Year: 2023 Document type: Article